In vitro study of pinostrobin propionate and pinostrobin butyrate: cytotoxic activity against breast cancer cell T47D and its selectivity index
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Backgrounds: Pinostrobin has the potential activity as an anti-cancer. However, its activity is still lower than the anticancer drugs on the market. To increase its activity, pinostrobin derivatives have been synthesized, namely pinostrobin propionate and pinostrobin butyrate, which are predicted to have better activity and lower toxicity than pinostrobin after being tested by in silico approach. So the compound deserves to be tested for its anticancer activity and selectivity on normal cells.
Objective: This study aims to determine the anticancer activity of pinostrobin propionate and pinostrobin butyrate against the T47D breast cancer cell line and its selectivity against the Vero cell line.
Methods: The cytotoxicity test which is anticancer activity test and its selectivity on normal cell were carried out using the MTT(3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay. The cells used were breast cancer cell line T47D and normal Vero cells. The test results were analyzed using a microplate reader with a wavelength of 570 nm.
Results: From the analysis of anticancer activity on T47D cells, the IC50 values of pinostrobin, pinostrobin propionate, and pinostrobin butyrate were 2.93, 0.57, and 0.40 mM, respectively. While the results of the cytotoxicity test on Vero cells obtained the CC50 value of pinostrobin, pinostrobin propionate, pinostrobin butyrate was 1.27, 0.94, and 0.89 mM, respectively. So the SI value of pinostrobin (SI=0.4) is smaller than its derivatives (SI=1.7 and 2.2). Meanwhile, pinostrobin butyrate is more selective than pinostrobin propionate.
Conclusions: It can be concluded that pinostrobin propionate and pinostrobin butyrate compounds have greater activity and selectivity than pinostrobin so these compounds are promising to be further developed as anticancer candidates.
The Global Cancer Observatory. 2020. Cancer Incident in Indonesia.
Atun S. Arianingrum R. Anticancer Activity of Bioactive Compounds from Kaempferia Rotunda Rhizome against Human Breast Cancer. Int J Pharmacognosy Phytochemical Res 2015;7:262–9.
Institute of Medicine. Breast Cancer and the Environment: A Life Course Approach. Nat Academies Press 2012.
Listyawati S, Sismindari, Mubarika S, et al. Anti-Proliferative Activity and Apoptosis Induction of an Ethanolic Extract of Boesenbergia pandurata (Roxb.) Schlecht against HeLa and Vero Cell Lines. Asian Pac J Cancer Prev 2016;17:183–7. DOI: https://doi.org/10.7314/APJCP.2016.17.1.183
Chahyadi A, Hartati R, Wirasutisna KR. Elfahmi. Boesenbergia pandurata Roxb. An Indonesian Medicinal Plant: Phytochemistry, Biological Activity, Plant Biotec. Procedia Chem 2014;13:13–37. DOI: https://doi.org/10.1016/j.proche.2014.12.003
Fadilah F, Edina BC, Rahmawati RA, et al. Molecular Dynamic of Pinostrobin and Pinocembrin from Kaempferia pandurata Roxb. towards Estrogen Receptor Positive (ESR) and Estrogen Receptor Negative (VEGFR) of Breast Cancer. Asian J Pharma 2018;12:S1473–80.
Sukardiman, Widyawaruyanti A, Widyowati R, et al. Pinostrobin Isolated from Kaempferia pandurata Roxb Induced Apoptosis in T47D Human Beast Cancer Cell Line 2014;2.
Husnunnisa F, Ismed M, Taher SJA, et al. Screening of Some Sumatran Medicinal Plants and Selected Secondary Metabolites for Their Cytotoxic Potential against MCF-7 and HSC-3 Cell Lines. J Res Pharm 2019;23:770–6. DOI: https://doi.org/10.12991/jrp.2019.186
Rosmelia RBE, Suryaningsih, Anshory H, Wirohadidjojo YW. The Cytotoxic Effect of Pinostrobin Fingerroot (Boesenbergia pandurata) on the Culture of Hela Cells. J Kedokteran Dan Kesehatan Indonesia 2009;7:137–42. DOI: https://doi.org/10.20885/JKKI.Vol7.Iss4.art4
Siswandono, Widyowati R, Suryadi A, et al. Molecular modeling, synthesis, and qsar of 5-o-acylpinostrobin derivatives as promising analgesic agent. Rasayan J Chem 2020;13:2559-2568. DOI: https://doi.org/10.31788/RJC.2020.1345749
Praditapuspa EN, Siswandono, Widiandani T. In Silico Analysis of Pinostrobin Derivatives from Boesenbergia pandurata on ErbB4 Kinase Target and QSPR Linear Models to Predict Drug Clearance for Searching Anti-Breast Cancer Drug Candidates. Pharmacognosy J 2021;13:1143–9. DOI: https://doi.org/10.5530/pj.2021.13.147
Agustin SL, Widiandani T, Hardjono S, Purwanto BT. QSAR of Acyl pinostrobin derivatives as Anti-breast cancer against HER-2 receptor and their ADMET properties based on in silico Study. Res J Pharm Tec 2022;15:4641-8. DOI: https://doi.org/10.52711/0974-360X.2022.00779
Barros AV, Araújo LM, De Oliveira FF, et al. Avaliação in Vitro Do Potencial Antiviral de Guettarda Angelica Contra Herpesvírus Animais. Acta Scientiae Veterinariae 2012;40.
Ambali OA, Ajaiyeoba EO, Ogbole OO, Adeniji JA. Ethnobotanical Survey of Plants Used for Cancer Treatment in Akinyele Local Government of Ibadan, Nigeria and Preliminary Cytotoxic Activity of Selected Plants. Nig J Pharm Res 2021;17:27–37. DOI: https://doi.org/10.4314/njpr.v17i1.3
Nogueira F, do Rosário VE. Methods for Assessment of Antimalarial Activity in the Different Phases of the Plasmodium Life Cycle. Revista Pan-Amazônica de Saúde 2010;1:109–24. DOI: https://doi.org/10.5123/S2176-62232010000300015
Vilková M, Hudáčová M, Palušeková N, et al. Acridine Based N‐ Acylhydrazone Derivatives as Potential Anticancer Agents: Synthesis, Characterization and CtDNA/HSA Spectroscopic Binding Properties. Molecules 2022;27. DOI: https://doi.org/10.3390/molecules27092883
Damasuri, Ridha A, et al., Cytotoxicity of ((E)-1-(4-aminophenyl)-3-phenylprop-2-en-1-one)) on Hela cell line. IJPTher 2020;1: 54-9. DOI: https://doi.org/10.22146/ijpther.606
Siswandono. Pengembangan Obat. In: Kimia Medisinal 1 Eds. Surabaya: Airlangga University Press 2016;11–58.
Pratama MRF, Poerwono H, Siswandono. Design and molecular docking of novel 5-O-Benzoylpinostrobin derivatives as anti-breast cancer, Thai J Pharma Sci 2019;43:201–12.
Copyright (c) 2023 the Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.